Navigation Links
New study shows promise in reducing surgical risks associated with surgical bleeding
Date:8/13/2007

CHICAGO (August 10, 2007) Surgeons may have a new patient safety tool to stop moderate surgical bleeding without some of the concerns associated with the current standard blood-clotting treatment. New research published in the August issue of the Journal of the American College of Surgeons shows that recombinant human thrombin (rhThrombin) reduces the risk of surgical complications associated with the use of plasma-derived bovine thrombin (bThrombin), which is currently the only commercially available stand-alone thrombin used to improve clotting during surgical procedures and stop bleeding.

Each year, bThrombin is used to treat more than one million patients who undergo surgical procedures in the United States. However, approximately 20 percent of these patients develop antibodies against bovine coagulation factors that can cross-react with human coagulation proteins and possibly lead to adverse effects, including severe bleeding and thrombosis. Due to these safety concerns, rhThrombin was developed as an alternative to bThrombin.

We constantly look for new ways to reduce risks in surgery and stopping surgical bleeding safely and effectively is of foremost interest to surgeons. The results from this phase III trial show that we can stop bleeding in 95 percent of patients within 10 minutes and do so without introducing foreign proteins that can carry greater risk of development of antibodies, said William C. Chapman, MD, FACS, Department of Surgery, Washington University, St. Louis (MO) School of Medicine. Im most encouraged by the increasing evidence that recombinant technology is safe and effective because it means that we may be able to avoid using blood or blood products from other people or animals and automatically diminish the risk of infection and the associated immunologic responses that have been noted in the past.

The randomized, double-blind comparative study included 411 patients who underwent surgical procedures at 3
'/>"/>

Contact: Sally Garneski
pressinquiry@facs.org
312-202-5409
Weber Shandwick Worldwide
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Gene study links endometriosis, infertility
2. Study reveals how stress can make you sick
3. Study points out that HIV vaccine may not be accepted easily
4. A new study surpasses Gene Therapy Hurdle
5. Tomato Sauce reduces Cancer Risk- Study
6. A question on study of Adult Stem Cell
7. Study on obesity and heart failure
8. National Lung Study in the process
9. Marijuana gateway theory strengthened by study of twins
10. Old theory of adaptation confirmed by new study
11. Study casts doubt on keyboard ills
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...rter financial results -, LAVAL, QC, July 25 /PRN...DAQ: DDSS) today announced that it will host a con... to discuss its second quarter 2008,financial resu... financial,results via news release at approximate...nce call by telephone, dial 416-646-3095 or,1-800-...
(Date:7/25/2008)...erweight or obese is not only a personal issue tha... issue that impacts other people in society. A new...eveals that the extra Medicare cost associated wit...ant financial burden on tax payers, costing up to ...current Medicare population. , The article,s fi...
(Date:7/25/2008)...Fourth Annual Physician On-Call Pay ...swire/ -- Sullivan, Cotter and Associates, Inc.,ha...on-call pay rates and,practices, the 2008 Physicia...th data from 132 healthcare organizations nationwi...ates paid for 33 physician specialty areas along,w...
(Date:7/25/2008)...ire/ -- Sagent Pharmaceuticals, Inc.,a privately-...nced that it,has launched amiodarone HCl injection...e treatment and prophylaxis of frequently recurrin...table ventricular,tachycardia -- a potentially lif...arone HCl injection will be available immediately ...
Breaking Medicine News(10 mins):Health News:Labopharm to host conference call Friday, August 8, 2008 at 8:30 A.M. (ET) 2Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 2Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 3Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 2Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 3
...the initial mammogram immediately so any follow-up...t. Between 5 percent and 11 percent of all screeni...ome back for a follow-up mammogram. Many abnormal ...g they do not result in a breast cancer diagnosis ...
...CPR on heart attack victims found they regularly g...ed for by American Heart Association CPR standards... minute, the EMS personnel were delivering on aver...perventilate. Even after personnel were retrained ...
...ck to heart disease, say researchers based on rece...ore exercise, the risk can be significantly reduce...re atherosclerosis -- the deadly build-up of plaqu... -- in the arm and neck arteries of kids. Even tho...
...coronavirus. Similar viruses infect the pigs and o... 2002 and spread to more than two dozen countries ...mmer. // More than 8,000 people worldwide were sic... mongoose-like animals that are sold in live food ...
Other Medicine News:Health News:SARS vaccine shows promise in Animal Testing 2
(Date:7/23/2008)... Work with Protein Therapeutics that Mod...AMBRIDGE, Mass., July 23 /- Taligen T...a corporate growth plan with the,appointment of Ab...d the,establishment of its headquarters in Cambrid...D., a co-founder of the company who remains presid...
(Date:7/22/2008)...s Development Initiative bring MJFF,s,current acti...nuary 20,2009, NEW YORK, July 22 /PRNewswire-USN...ry of transformative treatments and a cure for Par...r Parkinson,s Research has awarded,$2.7 million in... awards,were granted under MJFF,s Therapeutics Dev...
(Date:7/22/2008)... and Apidra(R) Resulted in Significant, Reductions... the Algorithm Us...sults from the "Adjust to,Target in Type 2 Diabete...e,Counting for Adjustment of Mealtime Insulin Glul...tes Association,s (ADA) medical journal,Diabetes ...
(Date:7/22/2008)...umbia University Medical Center Based on ..., The Test Differentiates Squamous From Non-Squa...ing Squamous-Cell Carcinoma of the Lung With ...Percent,This is the First CLIA Approved Test Which...arkers for Accurate Diagnosis of Lung Cancer, REH...
Breaking Medicine Technology:Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 3Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 2First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 5Advanced Energy Consortium will develop micro and nanosensors to boost energy production 2605 1Advanced Energy Consortium will develop micro and nanosensors to boost energy production 2605 2Pelosi Democrats Host Health Care Forum This Morning 9587 1Pelosi Democrats Host Health Care Forum This Morning 9587 2Pelosi Democrats Host Health Care Forum This Morning 9587 3Pelosi Democrats Host Health Care Forum This Morning 9587 4Wisconsin Physicians Service Insurance Corporation Files Suit Against Aurora Health Care and HealthEOS 9583 1Wisconsin Physicians Service Insurance Corporation Files Suit Against Aurora Health Care and HealthEOS 9583 2The Widener University Elder Pennsylvanian Survey Finds Pennsylvanias Baby Boomers Anticipate Working Longer Retiring Later to Help Offset Looming He 9579 1The Widener University Elder Pennsylvanian Survey Finds Pennsylvanias Baby Boomers Anticipate Working Longer Retiring Later to Help Offset Looming He 9579 2The Widener University Elder Pennsylvanian Survey Finds Pennsylvanias Baby Boomers Anticipate Working Longer Retiring Later to Help Offset Looming He 9579 3The Widener University Elder Pennsylvanian Survey Finds Pennsylvanias Baby Boomers Anticipate Working Longer Retiring Later to Help Offset Looming He 9579 4
...monstrates Utility in Evaluating Drug,Efficacy; Dr... HDL,Therapy , ,PLEASANTON, CA, Mar 30, 2007 (MARK..., Inc. (NASDAQ: LIPD) Dr. H. Bryan Brewer, Jr.,Ch...oncluded from,the wide range of presentations at t...ting in New Orleans that the rationale for HDL,bei...
...: Time to Pay Attention to this,Overlooked Disease...-- During,National Sexually Transmitted Disease (S...is urging increased awareness of, and,testing for,...common curable STD in the United States. Awareness...at trich affects an estimated 7.4,million men and ...
Other Medicine Technology:Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 2Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 3Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 4Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 5Trichomoniasis: Most Common Curable STD in U.S. Affects 7.4 Million,Annually 2Trichomoniasis: Most Common Curable STD in U.S. Affects 7.4 Million,Annually 3
LigaSure system generator, bipolar only. Designed to permanently seal vessels and tissue bundles.
Sabre 180 is a powerful niche generator.
Sabre 180 is a powerful niche generator.
The Sabre 2400 provides high power performance and key user features to meet today's demanding electrosurgical needs. It is an ideal general-purpose electrosurgical generator.
Medicine Products: